All issues
Volume 28, Issue 3
Displaying 1-5 of 5 articles from this issue
- |<
- <
- 1
- >
- >|
-
Shinji Nakao1999 Volume 28 Issue 3 Pages 104-110
Published: September 30, 1999
Released on J-STAGE: November 27, 2012
JOURNAL FREE ACCESSDownload PDF (3966K) -
Masahiro Imamura, Sumiko Kobayashi, Satoshi Hashino, Junji Tanaka1999 Volume 28 Issue 3 Pages 111-118
Published: September 30, 1999
Released on J-STAGE: November 27, 2012
JOURNAL FREE ACCESSDownload PDF (1011K) -
Akira Hiraoka1999 Volume 28 Issue 3 Pages 119-126
Published: September 30, 1999
Released on J-STAGE: November 27, 2012
JOURNAL FREE ACCESSDownload PDF (786K) -
Yoshihisa Nagatoshi, Jun Okamura1999 Volume 28 Issue 3 Pages 127-134
Published: September 30, 1999
Released on J-STAGE: November 27, 2012
JOURNAL FREE ACCESSDownload PDF (995K) -
Naoki Watanabe1999 Volume 28 Issue 3 Pages 135-145
Published: September 30, 1999
Released on J-STAGE: November 27, 2012
JOURNAL FREE ACCESSEndogenous tumor necrosis factor (enTNF) acts as a cross-resistant factor against the cytotoxicity caused by exogenous TNF, doxorubicin, and heat, not only via induction of manganous superoxide dismutase, but also via enhancement of the heat shock element binding activity of heat shock factor 1, followed by augmentation of HSP 72 expression. These findings suggest that prediction of the efficacy of various therapeutic modalities against cancer is possible by measurement of enTNF expression.View full abstractDownload PDF (1523K)
- |<
- <
- 1
- >
- >|